ADO 0.00% 2.4¢ anteotech ltd

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-57

  1. 4,323 Posts.
    lightbulb Created with Sketch. 13107
    just a little snippet they slipped in

    using nasal anterior samples, Eugeni achieved a sensisitivty of 96.7%. using samples from ct15- ct30. these were from direct patient samples and we only missed 1 out of 30.

    what will our Eugeni test provide with nasal pharyngeal samples (without VIDRL VTM interference) ? which from the last presentation is more accurate. if it doesn't miss that 1 positive it would be 30 out of 30. what % would that be??? come on TGA....

    ps. hopefully the quarterly was released a day earlier than usual to free up tomorrow...
 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
(20min delay)
Last
2.4¢
Change
0.000(0.00%)
Mkt cap ! $59.24M
Open High Low Value Volume
2.3¢ 2.4¢ 2.2¢ $42.79K 1.848M

Buyers (Bids)

No. Vol. Price($)
1 271944 2.3¢
 

Sellers (Offers)

Price($) Vol. No.
2.4¢ 851994 5
View Market Depth
Last trade - 16.10pm 12/09/2024 (20 minute delay) ?
ADO (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.